CSPC Hunan Jingfeng Pharmaceutical Co., Ltd. (SHE:000908)

China · Delayed Price · Currency is CNY

5.17

+0.04 (0.78%)

Oct 28, 2026, 3:04 PM CST

SHE:000908 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Revenue	413.9	378.11	416.03	656.89	840.66	811.18
Revenue Growth	5.27%	-9.12%	-36.67%	-21.86%	3.63%	-7.60%
Gross Profit	249.72	226.99	260.95	458.97	634.83	487.55
Operating Income	-48.13	-46.55	-5.31	-104.38	-19.44	-309.83
Net Income	-34.79	-80.89	152.3	-236.1	-122.56	-163.66
Earnings Per Share	-0.03	-0.09	0.17	-0.27	-0.14	-0.19
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Pharmaceuticals	363.7	391.27	629.71	787.86	628.89
Others	14.42	24.76	27.18	52.8	84.63
Total	378.11	416.03	656.89	840.66	811.18

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Investments	1,641	75.6	85.52	13.17	181.39	172.18
Total Debt	6.73	93.32	470.74	593.88	598.81	873.52
Net Cash (Debt)	1,634	-17.72	-385.22	-580.72	-417.42	-701.35
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	1.19	-0.02	-0.44	-0.66	-0.47	-0.80

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Operating Cash Flow	-13.56	59.32	-5.55	35.06	123.27	123.83
Capital Expenditures	-63.88	-4.57	-1.38	-10.42	-13.52	-38.12
Free Cash Flow	-77.45	54.76	-6.93	24.64	109.75	85.72
Free Cash Flow Growth	-	-	-	-77.55%	28.04%	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Gross Margin	60.33%	60.03%	62.72%	69.87%	75.52%	60.10%
Operating Margin	-11.63%	-12.31%	-1.28%	-15.89%	-2.31%	-38.19%
Pretax Margin	-7.44%	-20.52%	39.55%	-29.63%	-10.19%	-19.16%
Profit Margin	-8.41%	-21.39%	36.61%	-35.94%	-14.58%	-20.18%
FCF Margin	-18.71%	14.48%	-1.67%	3.75%	13.05%	10.57%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
PE Ratio	-	-	28.25	-	-	-
Forward PE	-	15.36	15.36	15.36	15.36	15.36
P/FCF Ratio	-	115.53	-	115.67	25.49	44.75
PS Ratio	21.98	16.73	10.34	4.34	3.33	4.73